 |
  |
||||||||
 |
|||||||||
|
|||||||||
 |
|||||||||
 |
|||||||||
|
|
 |
|
|
Products For Product Medical Information Contact 1-800-385-7034 |
|
|
|
Bepreve™ |
|
|
| Prescribing Information |
|
|
Material SafetyData Sheet |
|
|
|
|
|
Xibrom™ |
|
|
|
Prescribing Information |
|
Material SafetyData Sheet |
|
|
|
Vitrase® (hyaluronidase injection) Ovine 200 USP Units/mL |
|
|
|
Prescribing Information |
|
Material SafetyData Sheet |
|
|
|
|
|
Istalol® |
|
|
|
Prescribing Information |
|
Material SafetyData Sheet |
|
|
|
|
 |
||||
|
||||
|
||||
|
|
Overview ISTA Pharmaceuticals is developing one of the healthcare industry’s most comprehensive late-stage therapeutic pipelines to treat diseases of the eye. As the Company continues to progress, ISTA will position itself as a fully integrated specialty pharmaceutical company with a focus on ophthalmology, addressing substantial patient populations. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. The site is not intended to provide medical diagnosis or advice regarding any particular disease or condition. |
|
|
|
||
 |
|
 |
|
||
 |
||
|
||